(firstQuint)A Long-Term Safety Study of Asoprisnil in the Treatment of Uterine Fibroids.

.

 No medical therapy is currently available for the long-term treatment of uterine fibroids.

 The objective of this study is to determine the long-term safety of asoprisnil 10 mg daily for 6 months, after an initial 12 weeks in study M99-144, in women with one or more uterine fibroids, confirmed by ultrasound in study M99-144.

 The safety endpoints for this study will be based on ultrasound and endometrial biopsy results, adverse events, and any changes from baseline laboratory values and vital signs.

.

 A Long-Term Safety Study of Asoprisnil in the Treatment of Uterine Fibroids.

@highlight

This study was designed to determine the long-term safety of asoprisnil 10 mg in women with one or more uterine fibroids after an initial 12 weeks in study M99-144.

